Innovation Pharmaceuticals Announces Publication of Peer-Reviewed Scientific Article in the Journal Viruses on the Anti-SARS-CoV-2 Properties of Brilacidin
March 02, 2021 09:00 ET
|
Innovation Pharmaceuticals Inc.
Emerging mutations to the coronavirus are unlikely to affect Brilacidin’s ability to inhibit the virusBrilacidin currently is being evaluated in a Phase 2 clinical trial in hospitalized COVID-19...
Insights on the Polymerase Chain Reaction for Point-of-Care Diagnostics Global Market to 2025 - Impact Analysis of COVID-19
February 11, 2021 07:33 ET
|
Research and Markets
Dublin, Feb. 11, 2021 (GLOBE NEWSWIRE) -- The "Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics" report has been added to ResearchAndMarkets.com's offering. The scope of this...
Innovation Pharmaceuticals’ Phase 2 Clinical Trial of Brilacidin for Treating COVID-19 Scheduled to Begin Next Week
January 29, 2021 09:15 ET
|
Innovation Pharmaceuticals Inc.
Brilacidin treatment unlikely to be impacted by coronavirus variants, such as those originating in the U.K., South Africa and Brazil, and spreading worldwide, due to its ability to attack the virus...
2020 Insights on the Worldwide Medical Devices & Diagnostics Industry to 2021 - Affects of COVID-19 on Companies Including Medtronic, Abbott Laboratories & GE Healthcare
January 21, 2021 09:33 ET
|
Research and Markets
Dublin, Jan. 21, 2021 (GLOBE NEWSWIRE) -- The "The COVID Impact on Global Medical Devices & Diagnostics Markets: 2020 Review & 2021 Forecast" report has been added to...
United States Clinical Chemistry and Immunoassay In-Vitro Diagnostics Market Report 2020: Serology Assays for COVID-19 Diagnosis Present an Immediate Growth Opportunity
January 18, 2021 09:18 ET
|
Research and Markets
Dublin, Jan. 18, 2021 (GLOBE NEWSWIRE) -- The "Demand for High-Volume Testing Driving the Growth of the US Clinical Chemistry and Immunoassay In Vitro Diagnostics Market, 2020" report has been added...
FluroTech Announces Joint Venture Product Solution and Partners
November 10, 2020 08:45 ET
|
FluroTech Ltd.
CALGARY, Alberta, Nov. 10, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce, its previously announced joint venture...
FluroTech Formalizes Ownership Structure in FluroTest Joint Venture and Launches a Financing
November 05, 2020 08:45 ET
|
FluroTech Ltd.
CALGARY, Alberta, Nov. 05, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that FluroTest, LLC (the “LLC”), a company in...
EndSARS Protest: Majority Condemns Killings and Offers Free Calls To And From Nigeria
October 22, 2020 10:39 ET
|
MAJORITY
HOUSTON and STOCKHOLM, Oct. 22, 2020 (GLOBE NEWSWIRE) -- We are deeply saddened and concerned about the police brutality against protesters in Nigeria, which has already resulted in the deaths of at...
Global Coronavirus Diagnostics Market Report 2020-2025
September 30, 2020 04:54 ET
|
Research and Markets
Dublin, Sept. 30, 2020 (GLOBE NEWSWIRE) -- The "Global Coronavirus Diagnostics Market by Type of Test (Molecular v/s Serology), by User (Single v/s Multiple), by Full Test Time (Less Than 60...
Clinical Trial Shows Itolizumab Reduces Mortality in Patients Hospitalized with COVID-19
July 13, 2020 03:30 ET
|
Equillium
Equillium shares topline results of patients treated with itolizumab in clinical trial conducted in India by partner Biocon Biocon has received emergency use approval from Drugs Controller General of...